This meeting took place in 2018

Here are the related meetings in 2020:
Beyond a Million Genomes: From Discovery to Precision Health (A4)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

One Million Genomes: From Discovery to Health (G1)

Organizer(s) Geoffrey S. Ginsburg, Teri Manolio and Patrick Boon Ooi Tan
June 4—8, 2018
Herrenhausen Palace • Hannover, Germany
Discounted Abstract Deadline: Feb 21, 2018
Abstract Deadline: Mar 27, 2018
Scholarship Deadline: Feb 21, 2018
Discounted Registration Deadline: Apr 11, 2018

Organized in collaboration with Volkswagen Foundation
Sponsored by Regeneron Pharmaceuticals, Inc. and Vertex Pharmaceuticals Incorporated

Summary of Meeting:
The completion of the Human Genome Project in 2003 has catalyzed innovations in scientific research and in healthcare embodied in the term “precision medicine.” Across the globe, many nations are investing in large-scale national sequencing cohort programs, resulting in over one million human genomes sequenced and linked to dense phenotypic and clinical data. This Keystone Symposia conference will bring together scientists and leaders from healthcare and industry to discuss how to maximize the value of that investment for human health. It will assemble a unique and highly interdisciplinary international community to articulate how best to use these data-rich resources to provide novel insights into the biology of disease, tools for the management of patients and population health management strategies. The meeting will highlight challenges and potential solutions for germ-line and somatic sequencing programs and make recommendations for optimizing their impact on global health. The crucial role of free and open sharing and exchange of human variation data from these programs in allowing all of them to interpret novel variants and use them in clinical care will be emphasized. The symposium will focus on various scientific challenges for the field, including implementation science, the scalable data infrastructures and analyses required for impact on discovery and clinical care, and the value proposition for the investments that have been made in national programs. The leading edge of clinical impact of clinical sequencing will be highlighted in sessions on pharmacogenomics, and on developing novel therapeutics.

View Meeting Program


National Human Genome Research Institute (NHGRI) Scholarship Recipients

Brett Doble
University of Oxford, UK

Nicolo M. Dubacher
Foundation for People with Rare Diseases, Switzerland

Jakub Piotr Fichna
IMDiK PAN, Poland

John R. Giudicessi
Mayo Clinic, USA

Qi Ma
University of California, San Diego, USA

Luana Caroline Oliveira
Federal University of Parana, Brazil

Adria Jaume Roura Canalda
Nencki Institute of Experimental Biology of Polish Academy of Sciences, Poland

Volkswagen Stiftung Recipients
Funded by Volkswagen Stiftung

Oluyemi Akinloye
University of Lagos, Nigeria

James A. Balogun
College of Medicine, University of Ibadan, Nigeria

Diego A. Forero
Universidad Antonio Nariño, Colombia

Siana Watoky Nkya
Dar es Salaam University College of Education, Tanzania

Pornlada Nuchnoi
Faculty of Medical Technology, Mahidol University, Thailand

Nkiruka Nnonyelum Odunukwe
Nigerian Institute of Medical Research, Nigeria

Nusara Satproedprai
Medical Life Science Institute, Thailand